ÈùÏÙÑײ¡¶¾,Mumps virusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì©°²,Tai anÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÁ×å,the TusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éç»áÊÊÓ¦ÄÜÁ¦,Social adaptabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RhoGTPases,Rho GTPasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
WesternÔÓ½»,Western blottingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿·ËáĪÃ×ËÉ,mometasone furoateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
NO_2,nitrogen dioxideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔÔÙÕÏ,chronic aplastic anemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Þϸ°û²¡¶¾¸ÎÑ×,Cytomegalovirus hepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
9ºÅȾɫÌå,Chromosome 9Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Öéµ°°×Éú³ÉÕϰÐÔ,dysfunction of globin productionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¹Ìå3b,complement 3bÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àɸñ¶ûººË¹Ï¸°û,Langerhans cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºËÏ˲ã,Nuclear laminaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Cox·çÏÕÄ£ÐÍ,Cox risk modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ËÀײ®¸Ë¾ú,Klebsiella pneumoniaeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Å£Ä̵°°×,milk proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ËÀάËá¼Ø,Clavulanate potassiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀʸñººË¹Ï¸°û×é֯ϸ°ûÔöÉúÖ¢,Langerhans cell histiocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇÑÊ·ÖÃÚÎï,Nasopharyngeal secretionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÉÈÅËØ¦Á-1b,interferon ¦Á-1bÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î¶¯Âö°ê·´Á÷,Pulmonary regurgitationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó×¶ùÔ°,KindergartenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Chediak-Higashi×ÛºÏÕ÷,Chediak-Higashi SyndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
С³¦Áܰ͹ÜÀ©ÕÅÖ¢,Intestinal lymphangiectasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GATA4»ùÒò,GATA4 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»µäÐÍ´¨Æé²¡,Atypical Kawasaki DiseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÄÔ༡¸Æµ°°×I,cardiac troponin IÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÖØ»Ø¹é,multiple regressionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Î¿¼Æ½Ãæ,reference planeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃŶ¬°±Ëá,aspartic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÎÑ׺ϼÁ,Pneumonia mixtureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó¤Ó×¶ù´Ï¢,Infant wheezingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓ÷ÖÎö,GC-MSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
bro»ùÒò,bro geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¹³äºÍÌæ´úҽѧ,complementary and alternative medicineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔÃâÒßȱÏݲ¡,primary immunodeficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÌØ·¢ÐÔѪС°å¼õÉÙÐÔ×Ïñ°,Acute idiopathic thrombocytopenic purpuraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÖ×´²¡¶¾¸¹Ðº,Rotavirus diarrheaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éç»á¾¼Ãѧ,Social economicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌØ·¢ÐԷκ¬ÌúѪ»ÆËسÁ×ÅÖ¢,idiopathic pulmonary hemosiderosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔË®Ñù¸¹Ðº,acute watery diarrheaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÒÀÀµÐÍÌÇÄò²¡,Insulin dependent diabetes mellitusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÙ·¢ÐÔ¸¹Í´,Recurrent abdominal painÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ûËá±¶ÂÈÃ×ËÉ,beclometasone dipropionateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÈÌìÓÞÐÍ,Down syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¨ÖúÁÆ·¨,adjuvant therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦´«Êäʱ¼ä,colonic transit timeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎï·´Ó¦µ÷½Ú¼Á,Biological response modifierÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éö²¡Àí,Renal pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÖܾ²ÂöѪ,peripheral venous bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦Ñª¹Ü»îÐÔ¶àëÄ,vasoactive intestinal peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Ï¢ÐÔ¼²²¡,Asthmatic diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó¦Á¦Öµ,stress valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÍâ×é×°,Assembly in vitroÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔöʳÓûËØA,Orexin AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫºìµ°°×(Hb),hemoglobin (Hb)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Ð²î·ÖÎö,residual analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʵÑéÊÒÆÀ¹À,laboratory evaluationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°±»ùËá×¢ÉäÒº,amino acid injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅçÉäÎí»¯,spray atomizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÀàðåÕ¶¾6ÐÍ,human herpesvirus 6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÈÌìÐÔ¼²²¡,Congenital diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Tourette×ÛºÏÕ÷,Tourette syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô²×¶¶¯Âö¸É»ûÐÎ,Conotruncal defectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ù±û¶þËáѪ֢,methylmalonic acidemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎüÈëÐÔ±äÓ¦Ô,inhalation allergenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ«·Î²¡¶¾,MetapneumovirusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÂÈøÆæB×鲡¶¾,coxsackie B virusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢ÉúÎïÃô¸ÐÐÔʵÑé,microbial sensitivity testsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄòËØÃ¸ÊÔÑé,Urease testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Ú×´¶¯ÂöËðÉË,coronary artery lesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢С²¡¶¾B19,Parvovirus B19Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹À£Ññ²¡Ò©,anti-ulcer agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÐȾÏà¹ØÐÔÊÉѪϸ°û×ÛºÏÕ÷,infection-associated hemophagocytic syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Pierre Robin×ÛºÏÕ÷,Pierre Robin syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºôÎüµÀÖØËÜ,Airway remodelingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÕµ¼ÌµÒº,Induced sputumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨ÑÎÊä³ö±Ã,Bile salt export pumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°«Ð¡¶ùͯ,microsomia childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Á-ϸÐÁÄÔ×¢ÉäÒº,¦Á-asarone injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
McCune-Albright×ÛºÏÕ÷,McCune-Albright syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×óÐÄ·¿Ôö´ó,Left atrial enlargementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TBX5»ùÒò,TBX5 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿Ú·þ¿¹ÉúËØ,oral antibioticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ëľý×ӺϼÁ,Sijunzi MixtureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GÐÍ,G typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸´ÔÓ»ûÐÎ,Complex abnormalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÈáºìÃ¹ËØ,daunorubicin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÀà¶ËÁ£Ã¸´ß»¯Ñǵ¥Î»,Human telomerase reverse transcriptaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°×ÈýÏ©E4,leukotriene E4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
º£°²ÏØ,Haian CountyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØ×é¸ÉÈÅËØ,Recombinant interferonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ҽѧͼÏñ¿ÉÊÓ»¯,medical image visualizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»Í¬ÖÎÁÆ·½·¨,Different treatment methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¢ÌÇÏÙÜÕ,vidarabineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌúÔªËØ,ironÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍÈéÌÇÄÌ·Û,low lactose milk powderÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÔÁ×Ëữø,glycogen phosphorylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|